|Application ||WB, E|
|Calculated MW||11553 Da|
|Antigen Region||77-104 aa|
|Other Names||Platelet factor 4 variant, C-X-C motif chemokine 4 variant, CXCL4L1, PF4alt, PF4var1, Platelet factor 4 variant(4-74), Platelet factor 4 variant(5-74), Platelet factor 4 variant(6-74), PF4V1, CXCL4V1, SCYB4V1|
|Target/Specificity||This PF4V1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 77-104 amino acids from the C-terminal region of human PF4V1.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||PF4V1 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Inhibitor of angiogenesis. Inhibitor of endothelial cell chemotaxis (in vitro).|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
PF4V1 is an inhibitor of angiogenesis and endothelial cell chemotaxis (in vitro).
Davila, S., et al. Genes Immun. 11(3):232-238(2010)
Hillian, A.D., et al. Genes Immun. 9(6):501-508(2008)
Struyf, S., et al. Circ. Res. 95(9):855-857(2004)
Gevaert, K., et al. Nat. Biotechnol. 21(5):566-569(2003)
Eisman, R., et al. Blood 76(2):336-344(1990)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.